Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 8/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.35 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.34 |
| ▸ | HTR2C | P28335 | 1/20 | 0.34 |
| ▸ | MAOA | P21397 | 4/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL645949 | 0.74 | NQO2 (0.47) | CYP2A6MAPTMTNR1AMTNR1BHTR2A | |
| SCHEMBL20541051 | 0.72 | TXNRD1 (0.43) | CYP3A4CYP2A6LOXL2MAOBMAPT | |
| SCHEMBL30663731 | 0.70 | MAPT (0.56) | CYP3A4CYP2A6LOXL2MAOBMAPT | |
| SCHEMBL10347560 | 0.70 | MAPT (0.56) | CYP3A4CYP2A6LOXL2MAOBMAPT | |
| SCHEMBL30506059 | 0.70 | ELANE (0.40) | MTNR1AMTNR1BHTR2AHTR2C | |
| SCHEMBL28187711 | 0.70 | SCN9A (0.40) | MAPTMTNR1AMTNR1BHTR2AHTR2C | |
| SCHEMBL19038909 | 0.69 | CYP3A4 (0.57) | CYP3A4CYP2A6LOXL2MAOBMAPT | |
| SCHEMBL3198497 | 0.69 | CYP3A4 (0.49) | CYP3A4CYP2A6LOXL2MAOBMAPT | |
| SCHEMBL905744 | 0.69 | MTNR1A (0.42) | MAPTMTNR1AMTNR1BHTR2AHTR2C | |
| SCHEMBL19690941 | 0.69 | CYP3A4 (0.47) | CYP3A4CYP2A6LOXL2MAOBMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6372770-B1 | TREATING A MAMMAL SUFFERING FROM A DISEASE STATE SELECTED FROM THE GROUP CONSISTING OF ASTHMA, ALLERGIES, INFLAMMATION, DEPRESSION, DEMENTIA, ATOPIC DISEASES, RHINITIS AND DISEASE STATES ASSOCIATED WITH ABNORMALLY HIGH PHYSIOLOGICAL LEVELS OF | EURO-CELTIQUE, S.A. | 2002-04-16 | — | — | US | disclosed |